African-American men with low-risk prostate cancer treated with radical prostatectomy in an equal-access health care system: implications for active surveillance.
Rishi DekaJ Kellogg ParsonsDaniel R SimpsonPaul J RiviereVinit NalawadeLucas K VitzthumA Karim KaderChristopher J KaneChelsea S RockJames D MurphyBrent S RosePublished in: Prostate cancer and prostatic diseases (2020)
There was no significant difference in most adverse pathologic outcomes between AA and White patients. However, GG2 upgrading was more common in AA men. The implication is that AA may need to undergo additional evaluation, such as a biopsy MRI, before initiating AS. Whether the increase in GG2 upgrading will lead to poorer long-term clinical outcomes such as metastasis and PCSM also requires further investigation.
Keyphrases
- radical prostatectomy
- prostate cancer
- african american
- end stage renal disease
- magnetic resonance imaging
- chronic kidney disease
- middle aged
- peritoneal dialysis
- prognostic factors
- emergency department
- ultrasound guided
- patient reported outcomes
- radiation therapy
- squamous cell carcinoma
- lymph node
- skeletal muscle
- fine needle aspiration
- adverse drug
- weight loss
- clinical evaluation